Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

Sartorius Stedim Biotech SA DIM.PA

€163.31 €1.76 (1.09%) 1D

Last Updated: Jun 23, 12:00 AM·XPAR

DIM.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: October 21, 2025

Report Source: 2025 3rd Quarter Report

Analyst's Ratings for Sartorius Stedim Biotech SA (DIM.PA)

Based on 18 analysts giving stock ratings to Sartorius Stedim Biotech SA in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
17
Buy
61
Hold
22
Sell
0
Strong Sell
0
Sartorius Stedim Biotech SA

Sartorius Stedim Biotech SA. Stock Analysis DIM.PA

France Health Care Large Cap Report:
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
Read More

Sartorius Stedim Biotech SA (DIM.PA) Chart

Key Statistics of Sartorius Stedim Biotech SA (DIM.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€161.30€165.70

Today's Open

€161.55

Volume

92.35K

P/E Ratio (TTM)

59.33

52 Week Range

€150.00€224.00

Market Cap

15.94B

Avg. Volume

91.64K

Dividend Yield

0.43%

Financial Metrics & Statements of Sartorius Stedim Biotech SA (DIM.PA)

FAQ's for Sartorius Stedim Biotech SA (DIM.PA)

  • According to Musaffa’s Shariah screening methodology, Sartorius Stedim Biotech SA (DIM.PA) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sartorius Stedim Biotech SA using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Sartorius Stedim Biotech SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Sartorius Stedim Biotech SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Sartorius Stedim Biotech SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Sartorius Stedim Biotech SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.